federal_register: 97-11845

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
97-11845 New Animal Drugs for Investigational Use and New Animal Drug Applications; Reopening of Comment Period Proposed Rule The Food and Drug Administration (FDA) is reopening to June 9, 1997 the comment period for the advance notice of proposed rulemaking (ANPRM) for investigational use new animal drug (INAD) regulations and the new animal drug applications (NADA) regulations that published in the Federal Register of November 21, 1996. The comment period is being reopened for the sole purpose of inviting interested persons to submit comments that will give FDA guidance in developing proposed regulations defining ``good study practices.'' Elsewhere in this issue of the Federal Register, FDA is publishing a related document, a proposed rule further defining adequate and well-controlled studies. The definition of adequate and well-controlled studies requires that such a study, when conducted in the target animal, be conducted in compliance with good study practices. 1997-05-08 1997 5 https://www.federalregister.gov/documents/1997/05/08/97-11845/new-animal-drugs-for-investigational-use-and-new-animal-drug-applications-reopening-of-comment https://www.govinfo.gov/content/pkg/FR-1997-05-08/pdf/97-11845.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is reopening to June 9, 1997 the comment period for the advance notice of proposed rulemaking (ANPRM) for investigational use new animal drug (INAD) regulations and the new animal drug applications (NADA)...

Links from other tables